Nebivolol reduces short-term blood pressure variability more potently than irbesartan in patients with intradialytic hypertension

C Loutradis, A Bikos, V Raptis, Z Afkou, G Tzanis… - Hypertension …, 2019 - nature.com
Increased blood pressure (BP) variability (BPV) is associated with high cardiovascular risk in
hemodialysis. Studies on the effects of antihypertensive drugs on BPV in hemodialysis are …
被引用次数：17 相关文章

Nebivolol reduces short-term blood pressure variability more potently than irbesartan in patients with intradialytic hypertension

C Loutradis, A Bikos, V Raptis, Z Afkou… - HYPERTENSION …, 2019 - boa.unimib.it
Increased blood pressure (BP) variability (BPV) is associated with high cardiovascular risk in
hemodialysis. Studies on the effects of antihypertensive drugs on BPV in hemodialysis are …

Nebivolol reduces short-term blood pressure variability more potently than irbesartan in patients with intradialytic hypertension.

C Loutradis, A Bikos, V Raptis, Z Afkou… - … : Official Journal of the …, 2019 - europepmc.org
Increased blood pressure (BP) variability (BPV) is associated with high cardiovascular risk in
hemodialysis. Studies on the effects of antihypertensive drugs on BPV in hemodialysis are …

Nebivolol reduces short-term blood pressure variability more potently than irbesartan in patients with intradialytic hypertension

L Charalampos, B Athanasios… - Hypertension …, 2019 - search.proquest.com
Increased blood pressure (BP) variability (BPV) is associated with high cardiovascular risk in
hemodialysis. Studies on the effects of antihypertensive drugs on BPV in hemodialysis are …
[PDF] academia.edu

[PDF][PDF] Nebivolol reduces short-term blood pressure variability more potently than irbesartan in patients with intradialytic hypertension

C Loutradis, A Bikos, V Raptis, Z Afkou, G Tzanis… - …, 2019 - academia.edu
Increased blood pressure (BP) variability (BPV) is associated with high cardiovascular risk in
hemodialysis. Studies on the effects of antihypertensive drugs on BPV in hemodialysis are …

Nebivolol reduces short-term blood pressure variability more potently than irbesartan in patients with intradialytic hypertension

C Loutradis, A Bikos, V Raptis, Z Afkou, G Tzanis… - 2019 - pubmed.ncbi.nlm.nih.gov
Increased blood pressure (BP) variability (BPV) is associated with high cardiovascular risk in
hemodialysis. Studies on the effects of antihypertensive drugs on BPV in hemodialysis are …